ArticleMolecular and clinical oncology2024

Prognostic factors for non‑metastatic castration‑resistant prostate cancer treated with androgen receptor signaling inhibitors.

Kiyoshi Takahara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.